The organic chemistry of drug design and drug action

Verfasser / Beitragende:
Silverman, Richard B.; Holladay, Mark W.
Ort, Verlag, Jahr:
Amsterdam, Boston : Elsevier/AP, Academic Press, is an imprint of Elsevier, 2014
Beschreibung:
1 online resource (xviii, 517 pages) : illustrations (some color)
Format:
Buch (online)
Ausgabe:
Third edition / Richard B. Silverman, Northwestern University, Department of Chemistry, Department of Molecular Biosciences, Chemistry of Life Processes Institute, Center for Molecular Innovation and Drug Discovery, Evanston, Illinois, USA, Mark W. Holladay, Ambit Biosciences Corporation, Departments of Drug Discovery and Medicinal Chemistry, San Diego, California, USA.
ID: 528928406
LEADER cam a22 4500
001 528928406
003 CHVBK
005 20201014121020.0
006 m d
007 cr |n ||||||||
008 131029t20142014ne a sb 001 0 eng d
010 |a  2013043146 
020 |a 978-0-12-382030-3 (alk. paper) 
020 |a 0-12-382030-8 (alk. paper) 
035 |a (SERSOL)ssj0001184463 
035 |a (WaSeSS)ssj0001184463 
040 |a DLC  |b eng  |c DLC  |d DLC  |d WaSeSS  |e rda 
050 0 0 |a RS403  |b .S55 2014 
082 0 0 |a 615.1/9  |2 23 
100 1 |a Silverman  |D Richard B.  |e author 
245 1 4 |a The organic chemistry of drug design and drug action 
250 |a Third edition  |b Richard B. Silverman, Northwestern University, Department of Chemistry, Department of Molecular Biosciences, Chemistry of Life Processes Institute, Center for Molecular Innovation and Drug Discovery, Evanston, Illinois, USA, Mark W. Holladay, Ambit Biosciences Corporation, Departments of Drug Discovery and Medicinal Chemistry, San Diego, California, USA. 
264 1 |a Amsterdam  |a Boston  |b Elsevier/AP, Academic Press, is an imprint of Elsevier  |c [2014] 
264 4 |c ©2014 
300 |a 1 online resource (xviii, 517 pages)  |b illustrations (some color) 
336 |a text  |b txt  |2 rdacontent/eng 
337 |a computer  |b c  |2 rdamedia/eng 
338 |a online resource  |b cr  |2 rdacarrier/eng 
504 |a Includes bibliographical references and index. 
505 0 |a Introduction -- Lead discovery and lead modification -- Receptors -- Enzymes -- Enzyme inhibition and inactivation -- Dna-interactive agents -- Drug resistance and drug synergism -- Drug metabolism -- Prodrugs and drug delivery systems. 
506 |a Lizenzbedingungen können den Zugang einschränken. License restrictions may limit access. 
650 0 |a Pharmaceutical chemistry 
650 0 |a Bioorganic chemistry 
650 0 |a Molecular pharmacology 
650 0 |a Drugs  |x Design 
700 1 |a Holladay  |D Mark W.  |e author 
856 4 0 |u https://ebookcentral.proquest.com/lib/unibern/detail.action?docID=5754489  |z Uni Bern: Volltext 
856 4 0 |u https://www.sciencedirect.com/science/book/9780123820303  |z Uni Bern: Volltext 
898 |a BK020053  |b XK020053  |c XK020000 
909 4 |f Ebook Central All Subscribed Titles 
909 4 |f ScienceDirect eBooks 
909 4 |a E-Books von 360MarcUpdates 
949 |B IDSBB  |F B405  |b B405  |c 405VT  |x NELB4051809 
949 |B IDSBB  |F B405  |b B405  |c 405VT  |x NELB4051809 
950 |B IDSBB  |P 100  |E 1-  |a Silverman  |D Richard B.  |e author 
950 |B IDSBB  |P 700  |E 1-  |a Holladay  |D Mark W.  |e author 
950 |B IDSBB  |P 856  |E 40  |u https://ebookcentral.proquest.com/lib/unibern/detail.action?docID=5754489  |z Uni Bern: Volltext 
950 |B IDSBB  |P 856  |E 40  |u https://www.sciencedirect.com/science/book/9780123820303  |z Uni Bern: Volltext 
986 |a SWISSBIB  |b 132091720